CYTK Q3 2017 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-89.5% YoY

Gross Profit

-$19M-303.7% margin

Operating Income

-$28M-459.9% margin

Net Income

-$32M-523.6% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

+102.4%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$326M

Total Liabilities

$179M

Stockholders' Equity

$147M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$59M	-89.5%
Gross Profit	-$19M	$41M	-145.6%
Operating Income	-$28M	$32M	-187.5%
Net Income	-$32M	$33M	-197.0%